Previous 10 | Next 10 |
HALIFAX, NS / ACCESSWIRE / September 27, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) provides an update on its progress to achieve regulatory approval in Canada and the USA for its infectious disease rapid tests. Currently the Company has two submissions filed with Health Canada and one subm...
HALIFAX, NS / ACCESSWIRE / August 30, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) has completed, with its Transfer Agent, the process and has received confirmation by the TSX.v as follows: "Further to the resumption of trading of the shares of MedMira Inc., (the "Company"), the Exchange adv...
Mirion (NYSE: MIR) announced today that Chief Financial Officer, Brian Schopfer, will present at the Jefferies Industrials Conference in New York, NY. The presentation will begin at 9:00 AM ET on Wednesday, September 6, 2023. The presentation will be webcast live at https://ir.mirion.com/ne...
2023-08-28 04:26:35 ET Summary Mirion Technologies is a radiation detection and monitoring company with a market cap of $1.6 billion. Both the Medical and Industrial segments of the company outperformed market expectations in terms of revenue. But the bottom line is still negative...
2023-08-15 08:51:32 ET More on Mirion Technologies Mirion Technologies, Inc. ( MIR ) Q2 2023 Earnings Call Transcript Mirion Technologies ( MIR ) Presents At Industrials & Materials Conference - Slideshow Mirion Technologies beats top and bottom line Q2 est...
Agreement Focused on Unique Burn Up Measurement System (BUMS) in Development of the Xe-100 High-Temperature Gas-Cooled Reactor Mirion Technologies (NYSE: MIR), a leading provider of advanced radiation safety solutions, today announced a strategic design contract with X-Energy Reactor Co...
2023-08-02 15:38:04 ET Mirion Technologies, Inc. (MIR) Q2 2023 Earnings Conference Call August 02, 2023, 12:00 ET Company Participants Alex Gaddy - VP, IR Lawrence Kingsley - Chairman Thomas Logan - Founder, CEO & Director Brian Schopfer - CFO Confe...
2023-08-02 08:37:58 ET Mirion Technologies press release ( NYSE: MIR ): Q2 Non-GAAP EPS of $0.08 beats by $0.02 . Revenue of $197.2M (+12.2% Y/Y) beats by $6.71M . Net loss was $28.4 million in the second quarter, compared to a net loss of 59.3 million in the s...
Revenues for the second quarter increased 12.2% to $197.2 million, compared to $175.8 million in the same period last year. Net loss was $28.4 million in the second quarter, compared to a net loss of 59.3 million in the same period last year. Adjusted EBITDA was $44.3 million, a 4.0% ...
2023-08-01 13:14:25 ET Mirion Technologies ( NYSE: MIR ) is scheduled to announce Q2 earnings results on Wednesday, August 2nd, before market open. The consensus EPS Estimate is $0.06 (-53.8% Y/Y) and the consensus Revenue Estimate is $190.49M (+8.4% Y/Y). Over the las...
News, Short Squeeze, Breakout and More Instantly...
Mirion Technologies Inc. Class A Company Name:
MIR Stock Symbol:
NYSE Market:
Mirion Technologies Inc. Class A Website:
Mirion (NYSE: MIR) announced today that it will release financial results for second quarter 2024 after market close on Thursday, August 1, 2024. Following the news release, the company will host a conference call the next day, Friday, August 2, 2024, at 11:00 am ET to discuss the results. Pa...
HALIFAX, NS / ACCESSWIRE / July 2, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended April 30, 2024. Corporate update In Q3 FY2024, MedMira focused on the launch of MedMira's latest US FDA approved Reveal ® G4 Rapid HIV 1/2 antibody...
2024-06-23 05:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...